Cemtrex (CETX) had the highest return between 2002 and 2008 by a US stock, returning 102,360,057.8%.
| ASSET | YEARS | % RETURN |
|---|---|---|
Cemtrex (CETX) | 2002-2008 | 102,360,057.75% |
Future Fintech (FTFT) | 2002-2008 | 31,999,900% |
Eldorado Gold (EGO) | 2002-2008 | 12,664,100% |
InterContinental Hotels Group PLC ADR (IHG) | 2002-2008 | 5,411,100% |
Zivo Bioscience (ZIVO) | 2002-2008 | 4,363,536.36% |
NovaBay Pharmaceuticals (NBY) | 2002-2008 | 1,695,793.17% |
India Globalization Capital (IGC) | 2002-2008 | 1,616,566.67% |
Hirequest (HQI) | 2002-2008 | 924,250% |
Taoping (TAOP) | 2002-2008 | 863,957.6% |
NextTrip (NTRP) | 2002-2008 | 159,900% |
Ring Energy (REI) | 2002-2008 | 146,566.67% |
Danaos (DAC) | 2002-2008 | 104,359.73% |
ProMIS Neurosciences (PMN) | 2002-2008 | 64,385.98% |
Clean Energy Technologies, Inc Common Stock (CETY) | 2002-2008 | 48,386.36% |
Arena (AREN) | 2002-2008 | 37,924.69% |
CervoMed (CRVO) | 2002-2008 | 19,653.09% |
Live Ventures (LIVE) | 2002-2008 | 13,263.21% |
Ovintiv (OVV) | 2002-2008 | 11,843.73% |
NetEase (NTES) | 2002-2008 | 11,690.03% |
NanoViricides (NNVC) | 2002-2008 | 11,240% |
Xcel Brands (XELB) | 2002-2008 | 10,105.88% |
Hudbay Minerals (HBM) | 2002-2008 | 8,158.1% |
TherapeuticsMD (TXMD) | 2002-2008 | 7,439.95% |
Perspective Therapeutics (CATX) | 2002-2008 | 6,566.67% |
Monster Beverage (MNST) | 2002-2008 | 6,221.72% |
